InsiderDB

Lobbying disclosures · Lobbying report

BIIB: second_quarter 2026 lobbying report

Issues related to Alzheimer's Disease and treatment. Amyotrophic lateral sclerosis (ALS), Lou Gehrigs Disease and treatment and Lupus. Issues related to the budget and appropriations process Issues related to rare diseases and treatment. Issues related to Mental Health treatment. Issues related to maternal health. Issues related to the budget and appropriations process

Follow BIIB
Became public
Jul 20, 2026, 10:30 PM EDT
Event / period date
Not stated
Collected
Nov 10, 2026, 4:21 PM EST

Why this is connected

Exact legal-name match: BIOGEN INC. (https://www.sec.gov/Archives/edgar/data/875045/).

Reported lobbying amounts

Income: $50,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/7edb7a96-08c1-4226-8123-49ccfb471713/","filing_uuid":"7edb7a96-08c1-4226-8123-49ccfb471713","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7edb7a96-08c1-4226-8123-49ccfb471713/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Paul A. Brathwaite","dt_posted":"2026-07-20T22:30:58-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1220 L Street, NW","registrant_address_2":"Suite 100-401","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401104703,"url":"https://lda.gov/api/v1/registrants/401104703/","house_registrant_id":null,"name":"FEDERAL STREET STRATEGIES, LLC","description":"Government relations and public policy consulting firm","address_1":"1220 L Street, NW","address_2":"Suite 100-401","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL BRATHWAITE","contact_telephone":"+1 202-274-1099","dt_updated":"2026-07-30T23:17:42.705814-04:00"},"client":{"id":205465,"url":"https://lda.gov/api/v1/clients/205465/","client_id":164,"name":"BIOGEN, INC.","general_description":"Biotechnology Company.","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to Alzheimer's Disease and treatment. Amyotrophic lateral sclerosis (ALS), Lou Gehrigs Disease and treatment and Lupus. Issues related to the budget and appropriations process","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67337,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"BRATHWAITE","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Congressional Black Caucus; Deputy Assistant Secretary of Labor, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; and Special Assistant, U.S. Secretary of Labor, Department of Labor.","new":true},{"lobbyist":{"id":142566,"prefix":null,"prefix_display":null,"first_name":"VEN","nickname":null,"middle_name":null,"last_name":"NERALLA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Rep. Andy Levin; Deputy Chief of Staff,U.S. Rep. Pramila Jayapal; Legislative Director, U.S. Rep.Barbara Lee; Legislative Assistant, U.S. Rep. Peter DeFazio;Senior Advisor, USDA; OPP; and MCC.","new":true},{"lobbyist":{"id":147906,"prefix":null,"prefix_display":null,"first_name":"KAADE","nickname":null,"middle_name":null,"last_name":"WALLACE","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, U.S. Senator Amy Klobuchar; Staff Assistant, U.S. Representative Betty McCollum","new":true},{"lobbyist":{"id":147905,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"LEAVANDOSKY","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Zoe Lofgren; Senior Advisor, Committee on Science, Space & Technology; Senior Advisor, Committee on House Administration; Executive Director, California Democratic Congressional Delegation.","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to rare diseases and treatment. Issues related to Mental Health treatment. Issues related to maternal health. Issues related to the budget and appropriations process","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67337,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"BRATHWAITE","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Congressional Black Caucus; Deputy Assistant Secretary of Labor, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; and Special Assistant, U.S. Secretary of Labor, Department of Labor.","new":true},{"lobbyist":{"id":142566,"prefix":null,"prefix_display":null,"first_name":"VEN","nickname":null,"middle_name":null,"last_name":"NERALLA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Rep. Andy Levin; Deputy Chief of Staff,U.S. Rep. Pramila Jayapal; Legislative Director, U.S. Rep.Barbara Lee; Legislative Assistant, U.S. Rep. Peter DeFazio;Senior Advisor, USDA; OPP; and MCC.","new":true},{"lobbyist":{"id":147906,"prefix":null,"prefix_display":null,"first_name":"KAADE","nickname":null,"middle_name":null,"last_name":"WALLACE","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, U.S. Senator Amy Klobuchar; Staff Assistant, U.S. Representative Betty McCollum","new":true},{"lobbyist":{"id":147905,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"LEAVANDOSKY","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Zoe Lofgren; Senior Advisor, Committee on Science, Space & Technology; Senior Advisor, Committee on House Administration; Executive Director, California Democratic Congressional Delegation","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in BIIB

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.